Trademark: 78207781
Word
GET STEM
Status
Dead
Status Code
606
Status Date
Sunday, January 21, 2007
Serial Number
78207781
Mark Type
1000
Filing Date
Tuesday, January 28, 2003
Published for Opposition
Tuesday, October 28, 2003
Abandoned Date
Sunday, January 21, 2007

Trademark Owner History
Celgene Corporation - Owner At Publication

Classifications
5 pharmaceutical preparations for use with biological tissue intended for subsequent implantation; pharmaceutical preparations for use in the collection and preservation of human blood, umbilibal cord blood, stem cells, umbilibal cords and placentas; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations, namely, cytokine inhibatory drugs; pharmaceutical preparations for the treatment of oncology, inflamation, dermatology and opthamology diseases
42 research, development and testing services for others in the fields of biotechnology, chemistry and pharmaceuticals

Trademark Events
Mar 30, 2007
Abandonment Notice Mailed - No Use Statement Filed
Mar 30, 2007
Abandonment - No Use Statement Filed
Jun 7, 2006
Extension 5 Granted
Jun 7, 2006
Extension 5 Filed
Jun 7, 2006
Teas Extension Received
Dec 2, 2005
Extension 4 Granted
Nov 21, 2005
Extension 4 Filed
Nov 21, 2005
Teas Extension Received
Jul 6, 2005
Extension 3 Granted
Jul 6, 2005
Extension 3 Filed
Jul 6, 2005
Teas Extension Received
Jun 16, 2005
Teas Change Of Owner Address Received
Jan 13, 2005
Extension 2 Granted
Dec 28, 2004
Extension 2 Filed
Dec 28, 2004
Teas Extension Received
Jul 9, 2004
Extension 1 Granted
Jun 24, 2004
Extension 1 Filed
Jun 24, 2004
Teas Extension Received
Jan 20, 2004
Noa Mailed - Sou Required From Applicant
Oct 28, 2003
Published For Opposition
Oct 8, 2003
Notice Of Publication
Aug 25, 2003
Approved For Pub - Principal Register
Jul 18, 2003
Correspondence Received In Law Office
Jul 31, 2003
Case File In Ticrs
Jul 18, 2003
Teas Response To Office Action Received
Jul 8, 2003
Non-Final Action Mailed
Jul 7, 2003
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24